Selection of Transcatheter Heart vaLve With Intermediate Sizing in Patients With Severe Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 604 participants.

Also called NCT07689279

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 604 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07689279
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07689279. Randomized; no masking; primary purpose treatment. Start 2026-08-01 (anticipated); primary completion 2033-08-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Selection of Transcatheter Heart vaLve With Intermediate Sizing in Patients With Severe Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement
Acronym
SELECT TAVR
Condition
Aortic Stenosis, Severe
Intervention (Device)
Transcatheter Heart Valve
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (class: other)

Record details

Record id
cardio:ct-nct07689279
Content hash
58eb74591128ad57ef33bf9fba759207210769ac26af8ee0672a8c32a8c9ddb7